<DOC>
	<DOCNO>NCT01697566</DOCNO>
	<brief_summary>The goal clinical research study learn effect metformin and/or program call `` lifestyle intervention '' endometrium ( inner line uterus ) post-menopausal woman also obese ( risk factor endometrial cancer ) . Researchers also want learn insulin level affect metformin , diet and/or exercise . Metformin design treat diabetes insulin resistance . Insulin resistance condition body make insulin use properly . It often refer `` pre-diabetes '' . Many people insulin resistance high level sugar insulin blood time , report patient endometrial cancer . In study , metformin compare placebo . A placebo drug . It look like study drug design treat disease illness . It design compare study drug learn study drug real effect . Lifestyle intervention make series in-person session meet coach discus strategy lose weight way increase physical activity . It also consist material design help lose weight offer opportunity supervise exercise .</brief_summary>
	<brief_title>An Endometrial Cancer Chemoprevention Study Metformin</brief_title>
	<detailed_description>Study Groups : If find eligible take part study , randomly assign ( roll dice ) 1 4 study group : - Metformin . - Placebo lifestyle intervention . - Metformin lifestyle intervention . - Placebo . Neither study staff know receive metformin placebo . However , need safety , study staff able find receiving . In first month gradually increase dose metformin/placebo mouth list : - Week 1 : One capsule day - Week 2 : One capsule 2 time day - Week 3 : One capsule 3 time day - Week 4 : Two capsule 2 time day After week 4 , continue take 2 capsule metformin/placebo 2 time day . If receive lifestyle intervention , 16 lifestyle intervention session 4 month . At session , discuss method manage weight . You receive print material worksheet , measure utensil , food scale . You instruct use material often use study . You also provide opportunity supervise exercise ( group exercise class group walk ) . If travel schedule session , perform telephone . Each call last 30 minute , discuss goal information would discuss in-person session . Study Visits : Before begin receive study drug/placebo : - At second screen visit , dual energy x-ray absorptiometry ( DEXA ) scan measure body composition . The scan require lie still table 8-10 minute low-energy x-ray take image allows study staff get image body fat density . - You give accelerometer ( small , portable device measure physical activity ) taught use first Screening Visit . You wear accelerometer time awake 7 day . At second Screening Visit , return accelerometer intervention session . If able return second visit mail back study staff pre-paid envelope . You receive accelerometer Month 4 wear another 7 day . - You receive study diary record exercise perform day study . It take 5 minute complete time . - You complete questionnaire diet exercise . These questionnaire take 30-40 minute complete . - You also teach complete questionnaire internet record food eat 24 hour period . You 3 time 2 week period . The first time , complete clinic . The study staff call remind complete questionnaire 2 time . Each time complete questionnaire , take 40 minute . At Month 1 , participant return study visit . The following test procedure perform : - Blood ( 2 teaspoon ) draw routine test . If blood draw show liver kidney function abnormal , need return additional blood °draw Month 2 . - If symptom would describe moderate bad , non-pelvic physical exam include measurement vital sign unreported symptom may . At month , ask symptom ( ) may learn related study . If call , phone call last 5 minute . If ask in-person visit , visit last hour . Length Study : You receive study drug/placebo and/or lifestyle intervention 4 month . You take study intolerable side effect develop endometrial cancer hyperplasia study . Your participation study end-of-study visit . Post-Treatment Visit : At end 4th month , post-treatment visit . You repeat procedure perform first second visit : - Your height , weight , waist , hip circumference measure . - You DEXA scan . - You complete questionnaire food , diet , exercise . - You give questionnaire satisfaction ( base intervention ) complete return visit . This questionnaire take hour complete . - You endometrial biopsy . - Blood ( 8 tablespoon ) draw routine test biomarker test . You fast ( eat drink anything except water ) 12 hour blood draw . - You complete questionnaire internet record food eat 24 hour period . You 3 time 2 week period . The first time , complete clinic . The study staff call remind complete questionnaire 2 time . Each time complete questionnaire , take 40 minute . Follow-Up : About 1 year screen visit ( +/- 1 month ) , follow test procedure perform : - Your height , weight , waist , hip circumference measure . - You DEXA scan . - Blood ( 8 tablespoon ) draw routine test biomarker test . °You fast ( eat drink anything except water ) 12 hour blood draw . - You wear accelerometer 7 day . - You complete questionnaire food , diet , exercise . - You complete questionnaire internet record food eat 24 hour period . You 3 time 2 week period . The first time , complete clinic . The study staff call remind complete questionnaire 2 time . Each time complete questionnaire , take 40 minute . This investigational study . Metformin FDA approve commercially available treatment diabetes insulin resistance . Up 100 patient take part study . All enrol MD Anderson Cancer Center .</detailed_description>
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . For study , woman enrol . 2 . Body Mass Index ( BMI ) &gt; = 30 kg/m2 3 . Not frankly diabetic , measure fast blood glucose &lt; /=126 mg/dL . 4 . Demonstrate hyperinsulinemia QUICK I value &lt; /= 0.357 . 5 . Age &gt; /= 50 &lt; /= 65 6 . Zubrod Performance Scale 01 7 . Hemoglobin &gt; /= 10 g/dl 8 . TSH 0.27 4.20 µlU/mL 9 . Menopause define menses 1 year and/or FSH &gt; /= 25.8 mIU/ml 10 . Must able read , write , speak English . 11 . Must Primary Care Provider ( PCP ) . 1 . Prior hysterectomy endometrial ablation 2 . ALT &gt; /r = 2.0x Upper Limit Normal ( ULN ) 3 . Serum creatinine &gt; /= 1.4 mg/dl 4 . Triglycerides ( fast ) &gt; / = 400 5 . Known inability participate ongoing appointment four month study schedule followup test . 6 . Significant medical psychiatric history would make participant poor protocol candidate , opinion principal investigator , aspect study participation include metformin , unsupervised exercise program dietary behavior change . 7 . Participant report history congestive heart failure 8 . Prior treatment Metformin 9 . Currently treat diabetes meet criterion new diagnosis diabetes . 10 . Known allergy Metformin biguanide ( Proguanil ) . 11 . Use Aromatase Inhibitors , GNRHagonists i.e.Lupron , Zoladex within last 6 month 12 . Use SERMS ( selective estrogen receptor modulators ) past 6 month , include Tamoxifen Raloxifene 13 . Hormone replacement therapy within last 6 month 14 . Women treat chemotherapy prior malignant disease currently untreated malignancy nonmelanoma skin cancer 15 . Patients prior radiation pelvis</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Gynecology</keyword>
	<keyword>Endometrial Cancer Chemoprevention</keyword>
	<keyword>Obese</keyword>
	<keyword>Body Mass Index ( BMI ) &gt; /= 35 kg.m2</keyword>
	<keyword>Post-menopausal</keyword>
	<keyword>Hyperinsulinemia</keyword>
	<keyword>Metformin</keyword>
	<keyword>Placebo</keyword>
	<keyword>Sugar pill</keyword>
	<keyword>Lifestyle intervention</keyword>
	<keyword>Diet</keyword>
	<keyword>Exercise</keyword>
</DOC>